drugset / Trial / NCT00221468

A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents

NCT00221468

Phase 3 Completed 20 enrolled University of Cincinnati AstraZeneca · collab
NaSingle-groupSingle-blindTreatment

Summary

The purpose of this research study is to obtain preliminary data regarding the effectiveness, tolerability, and safety of quetiapine therapy for adolescents who have a mood disorder and have at least one parent with bipolar disorder (severe mood swings).

Timeline

Start
2003-06
Primary completion
2006-04
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule 600 mg

Indications